New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly ...

Thierry André and colleagues recently reported that nivolumab–ipilimumab provided an impressive absolute progression-free survival benefit at 36 months, which was 17% compared with nivolumab ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

SAN DIEGO and SUZHOU, China and SPRING HOUSE, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) ...

Archival specimens of consecutive patients with gastric MALT lymphoma tissue of last 3 years were obtained from the Pathology Department of Meir Hospital. All specimens of which enough DNA could be ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...

Microsatellite instability and loss of heterozygosity has been implicated in ovarian carcinogenesis. The reported frequency of microsatellite instability in human ovarian cancer varies significantly ...

The gastroenterologist performs an upper gastrointestinal endoscopy to examine the gastric mucosa, and typically takes ...

Want your own microsatellite constellation? The prospect just became much more realistic. Rocket Lab, a space startup out of California and New Zealand, announced two important firsts in the past week ...

Tel Aviv-based start up Effective Space Solutions claims that its DeOrbiter microsatellites could not only be used to dispose of defunct geosynchronous satellites, but could also rescue a pair of ...